Qiming Leads $20M Round In Chinese Start-Up Connect Biopharmaceuticals

This Data Is Locked!

This area is available only to Subscribers.

Qiming Venture Capital has led a US$20 million series A round in Connect Biopharmaceuticals Ltd., a clinical-stage company developing immune modulators for autoimmune diseases and... [DATA LOCKED]

UNLOCK DATA

Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals

Access Thousands of Data Points to Monitor Chinese Private Equity Deal Movement and Relationships

Already Have an Account?